Klinické štúdie Astma v štáte Texas
20 štúdií pre Astma hľadá účastníkov v zariadeniach v štáte Texas.
Mestá v štáte Texas
- Dallas10 štúdií
- Houston8 štúdií
- San Antonio6 štúdií
- Austin5 štúdií
- McKinney5 štúdií
- El Paso4 štúdií
- The Woodlands3 štúdií
- Cypress3 štúdií
- Sugar Land3 štúdií
Oficiálny text štúdie (anglicky)
A Study to Compare Safety of 4 Weeks Exposure to Propellants Hydrofluoroalkane 1,1-difluoroethane (HFA-152a) and HFA-1,1,1,2-tetrafluoroethane (134a)
- GSK Investigational Site, Cypress
- GSK Investigational Site, Tomball
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 30. 9. 2026 · NCT07645248A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma
- GSK Investigational Site, Dallas
- GSK Investigational Site, Kerrville
Prebieha náborFáza 3
Vek 12 až 17 · Všetky pohlavia · Aktualizované 30. 9. 2026 · NCT05757102Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids
- Research Site, Austin
- Research Site, Boerne
- Research Site, Dallas
- a 6 ďalších
Prebieha náborFáza 2
Vek 18 až 75 · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT06932263ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults
- Enveda Investigative Site, McKinney
Prebieha náborFáza 2
Vek 18 až 75 · Všetky pohlavia · Aktualizované 24. 9. 2026 · NCT07301255A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)
- Research Site 17, San Antonio
- Research Site 07, Sugar Land
Prebieha náborFáza 3
Vek 12 až 80 · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07359846A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
- South Texas Medical Research Institute, Inc., DBA TTS Research, Boerne
- Horizon Clinical Research Group, Cypress
- Alina Clinical Trials, LLC., Dallas
- a 2 ďalších
Prebieha náborFáza 2
Vek 18 až 70 · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT06977581A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma
- Research Site, Dallas
- Research Site, Houston
- Research Site, San Antonio
Prebieha náborFáza 3
Vek 5 až 11 · Všetky pohlavia · Aktualizované 21. 9. 2026 · NCT06023589A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)
- Research Site 24, Amarillo
- Research Site 19, Baytown
- Research Site 07, Dallas
- a 6 ďalších
Prebieha náborFáza 3
Vek 12 až 80 · Všetky pohlavia · Aktualizované 21. 9. 2026 · NCT07276724A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
- Teva Investigational Site 12083, Austin
- Teva Investigational Site 12060, Austin
- Teva Investigational Site 12179, Cypress
- a 13 ďalších
Prebieha náborFáza 3
Vek 12 a viac · Všetky pohlavia · Aktualizované 31. 8. 2026 · NCT06664619A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared to BFF in Participants of 4 to Less Than 12 Years of Age With Asthma
- Research Site, Lewisville
- Research Site, San Antonio
Prebieha náborFáza 2
Vek 4 až 11 · Všetky pohlavia · Aktualizované 27. 8. 2026 · NCT07525375A Study of Efficacy and Safety of Depemokimab Compared With Placebo in Adults and Adolescents With at Risk Type 2 Asthma
- GSK Investigational Site, San Antonio
Prebieha náborFáza 3
Vek 12 a viac · Všetky pohlavia · Aktualizované 17. 8. 2026 · NCT07456033Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
- Research Site, Austin
- Research Site, Baytown
- Research Site, Beaumont
- a 12 ďalších
Prebieha náborFáza 3
Vek 12 až 17 · Všetky pohlavia · Aktualizované 13. 8. 2026 · NCT06307665A Comparative Study to Investigate the Difference in Blood Levels of Two Different Formulations of GSK5784283
- GSK Investigational Site, Austin
Prebieha náborFáza 1Vítaní zdravých dobrovoľníkov
Vek 18 až 60 · Všetky pohlavia · Aktualizované 29. 7. 2026 · NCT07712393A Clinical Study to Evaluate the Efficacy and Safety of Frevecitinib (KN-002) in Patients With Severe Asthma
- Research site, Dallas
- Research site, Houston
- Research site, San Antonio
Prebieha náborFáza 2
Vek 18 až 75 · Všetky pohlavia · Aktualizované 28. 7. 2026 · NCT07532265Use of fenoTRACK Device for Monitoring Changes of Fractional Exhaled Nitric Oxide (FeNO) in Uncontrolled Asthma Subjects and Controlled Asthma Subjects
- Orion Clinical Research, Austin
- Pharmaceutical Research & Consulting, Inc., Dallas
- Western Sky Medical Research, El Paso
Prebieha náborObservačná štúdia
Vek 5 až 100 · Všetky pohlavia · Aktualizované 2. 6. 2026 · NCT07228026Escitalopram in Asthma Patients With Frequent Exacerbation
- UT Southwestern, 1440 Empire Central, Ste. LD4.100, Dallas
Prebieha náborFáza 2
Vek 18 až 75 · Všetky pohlavia · Aktualizované 26. 1. 2026 · NCT06216535Metformin IN Asthma for Overweight and Obese Individuals (MINA)
- Baylor College of Medicine, Houston
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 16. 1. 2026 · NCT06273072Asthma Intervention With Residential Ventilation and Air Cleaner (AIRVAC) Study
- University of Texas at Arlington, Arlington
- Rebuilding Together North Texas, Plano
Prebieha nábor
Vek 5 a viac · Všetky pohlavia · Aktualizované 29. 10. 2025 · NCT07196436Individualizing Treatment for Asthma in Primary Care (Full Study)
- JPS Health Network, Fort Worth
- Kelsey Research Foundation, Houston
Prebieha náborFáza 4
Vek 13 až 75 · Všetky pohlavia · Aktualizované 29. 10. 2025 · NCT07052942Viral Mucosal Reprogramming
- University of Texas Medical Branch, Galveston
Prebieha náborFáza 2Vítaní zdravých dobrovoľníkov
Vek 18 až 60 · Všetky pohlavia · Aktualizované 28. 1. 2025 · NCT05331170Z ClinicalTrials.gov, dáta načítané 4. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.